Previous Close | 182.04 |
Open | 181.37 |
Bid | 182.83 x 800 |
Ask | 183.41 x 800 |
Day's Range | 179.48 - 186.75 |
52 Week Range | 113.36 - 320.54 |
Volume | |
Avg. Volume | 459,081 |
Market Cap | 6.574B |
Beta (5Y Monthly) | 0.97 |
PE Ratio (TTM) | 78.06 |
EPS (TTM) | 2.33 |
Earnings Date | Feb 16, 2023 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 243.25 |
Subscribe to Yahoo Finance Plus to view Fair Value for SWAV
Shockwave Medical (SWAV) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. Small-cap stocks posted solid returns in the fourth quarter for the first time in 2022. The Russell 2000 Growth Index was up 4.11% trailing the Russell 2000 […]
Guidance Expands Number of Hospitals that Can Access IVL to Include Sites Where Calcium Modification Tools Were Previously Not RecommendedSANTA CLARA, Calif., Jan. 31, 2023 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular disease, today announced that coronary IVL was included in a treatment guidance document published by the Society of Cardiovascular Angiography and Intervention